EP2747562A4 - Östrogenrezeptorliganden und verfahren zu ihrer verwendung - Google Patents

Östrogenrezeptorliganden und verfahren zu ihrer verwendung

Info

Publication number: EP2747562A4
Authority: EP; European Patent Office
Prior art keywords: methods; same; estrogen receptor; receptor ligands; ligands
Prior art date: 2011-08-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP12834287.0A

Other languages

English (en)

French (fr)

Other versions

EP2747562A1 (de

Inventor

James Dalton

Mitchell S Steiner

Christopher C Coss

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oncternal Therapeutics Inc

Original Assignee

GTx Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-23

Filing date

2012-08-23

Publication date

2015-05-06

2011-08-23 Priority claimed from US13/215,679 external-priority patent/US9427418B2/en

2012-08-23 Application filed by GTx Inc filed Critical GTx Inc

2012-08-23 Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en

2014-07-02 Publication of EP2747562A1 publication Critical patent/EP2747562A1/de

2015-05-06 Publication of EP2747562A4 publication Critical patent/EP2747562A4/de

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

EP12834287.0A 2011-08-23 2012-08-23 Östrogenrezeptorliganden und verfahren zu ihrer verwendung Withdrawn EP2747562A4 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13/215,679 US9427418B2 (en)	2009-02-23	2011-08-23	Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en)	2009-02-23	2012-08-23	Estrogen receptor ligands and methods of use thereof

Publications (2)

Publication Number	Publication Date
EP2747562A1 EP2747562A1 (de)	2014-07-02
EP2747562A4 true EP2747562A4 (de)	2015-05-06

Family

ID=48444651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP12834287.0A Withdrawn EP2747562A4 (de)	2011-08-23	2012-08-23	Östrogenrezeptorliganden und verfahren zu ihrer verwendung

Country Status (10)

Country	Link
EP (1)	EP2747562A4 (de)
JP (1)	JP2014524479A (de)
KR (1)	KR20140064906A (de)
CN (1)	CN103957706A (de)
AU (1)	AU2012312902B2 (de)
CA (1)	CA2845890A1 (de)
IL (1)	IL231070A0 (de)
IN (1)	IN2014DN01959A (de)
MX (1)	MX2014002105A (de)
RU (1)	RU2014111060A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL273195B2 (en) *	2017-09-27	2024-04-01	Targimmune Therapeutics Ag	Castration-resistant prostate cancer
EP3917519A1 (de) *	2019-01-30	2021-12-08	Aragon Pharmaceuticals, Inc.	Antiandrogene zur behandlung von metastasierendem kastrationsempfindlichem prostatakrebs
JP2022523746A (ja) *	2019-02-01	2022-04-26	フォンダツィオーネ・ペア・リスチチュート・オンコロジコ・ディ・リチェルカ・（イオエッレ）	去勢抵抗性前立腺がんを処置する方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007062230A2 (en) *	2005-11-28	2007-05-31	Gtx, Inc.	Nuclear receptor binding agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8546451B2 (en) *	2005-11-28	2013-10-01	Gtx, Inc.	Estrogen receptor ligands and methods of use thereof
US8158828B2 (en) *	2005-11-28	2012-04-17	Gtx, Inc.	Nuclear receptor binding agents
JP5611991B2 (ja) *	2009-02-23	2014-10-22	ジーティーエックス・インコーポレイテッド	Ａｄｔのための医薬の製造におけるエストロゲン受容体リガンドの使用方法

2012
- 2012-08-23 EP EP12834287.0A patent/EP2747562A4/de not_active Withdrawn
- 2012-08-23 CN CN201280051979.4A patent/CN103957706A/zh active Pending
- 2012-08-23 JP JP2014527312A patent/JP2014524479A/ja active Pending
- 2012-08-23 KR KR1020147007549A patent/KR20140064906A/ko not_active Withdrawn
- 2012-08-23 CA CA2845890A patent/CA2845890A1/en not_active Abandoned
- 2012-08-23 RU RU2014111060/15A patent/RU2014111060A/ru not_active Application Discontinuation
- 2012-08-23 IN IN1959DEN2014 patent/IN2014DN01959A/en unknown
- 2012-08-23 MX MX2014002105A patent/MX2014002105A/es unknown
- 2012-08-23 AU AU2012312902A patent/AU2012312902B2/en not_active Ceased
2014
- 2014-02-20 IL IL231070A patent/IL231070A0/en unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007062230A2 (en) *	2005-11-28	2007-05-31	Gtx, Inc.	Nuclear receptor binding agents

Also Published As

Publication number	Publication date
AU2012312902B2 (en)	2016-03-17
AU2012312902A1 (en)	2013-05-23
MX2014002105A (es)	2014-09-25
CN103957706A (zh)	2014-07-30
JP2014524479A (ja)	2014-09-22
IL231070A0 (en)	2014-03-31
IN2014DN01959A (de)	2015-05-15
RU2014111060A (ru)	2015-09-27
EP2747562A1 (de)	2014-07-02
KR20140064906A (ko)	2014-05-28
CA2845890A1 (en)	2013-03-28

Similar Documents

Publication	Publication Date	Title
IL284407B (en)	2022-12-01	Opioid receptor ligands and methods for their use and preparation
EP2598630A4 (de)	2013-10-23	Neue bakterien und verfahren zu ihrer anwendung
EP2563813A4 (de)	2013-10-02	Anti-c5a-antikörper und anwendungsverfahren dafür
EP2606670A4 (de)	2015-05-27	Verfahren zur punktassoziation für kooperative mehrpunkt-übertragung
EP2593098A4 (de)	2014-02-05	Verfahren und zusammensetzungen für eine krebs-immuntherapie
EP2794928A4 (de)	2015-09-16	Zusammensetzungen und verfahren zum nachweis von analyten
EP2935628A4 (de)	2016-08-10	Zusammensetzungen und verfahren für aptamer-screening
EP2809262A4 (de)	2015-10-07	Implantatvorrichtungen und verfahren für aneurysma
EP2579828A4 (de)	2014-01-22	Verfahren und vorrichtung zur hemmung von narbenbildung
EP2538785A4 (de)	2013-10-30	Verfahren für die synthese von diarylthiohydantoin- und diarylhydantoinverbindungen
EP2252631A4 (de)	2012-06-27	Bcr-komplex-spezifische antikörper und verfahren zu ihrer verwendung
EP2726493A4 (de)	2015-03-18	Verfahren und zusammensetzungen zur selektiven regulierung einer proteinexpression
EP2542576A4 (de)	2013-09-04	Verfahren zum screening von antikörpern
EP2848072A4 (de)	2016-01-13	Verfahren und vorrichtungen für verbesserten zeitgerechten durchsatz für integrierte heterogenen multi-rat-netzwerke
EP2731617A4 (de)	2015-07-01	Lipidhaltige psa-zusammensetzungen, verfahren zu ihrer isolierung und verwendungsverfahren dafür
EP2521777A4 (de)	2014-04-02	Zusammensetzungen und verfahren zur behandlung von glioblastomen (gbm)
EP2750509A4 (de)	2015-03-04	Verfahren zur erzeugung von kardiomyozyten
EP2773358A4 (de)	2015-12-02	Zusammensetzungen und verfahren zur blutstillung
FR2955747B1 (fr)	2012-03-02	Moyen de reglage pour vetement
EP2760887A4 (de)	2015-06-10	Zusammensetzungen und verfahren zur hämostasenmodulierung
EP2756161A4 (de)	2015-08-26	Verfahren zur verwendung von ölhaltigen flüssigkeiten für abschlussoperationen
EP2909181A4 (de)	2016-03-23	Pkm2-modulatoren und verfahren zu deren verwendung
EP2890342A4 (de)	2016-05-18	Elektrische vorrichtung sowie verfahren und vorrichtung zur positionierung und implantierung von komponenten davon
EP2931280A4 (de)	2016-06-01	Verfahren und zusammensetzungen zur hemmung von cnksr1
EP2250189A4 (de)	2012-07-04	Gylcopeptide sowie verfahren zu ihrer herstellung und verwendung

Legal Events

Date	Code	Title	Description
2014-05-30	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2014-07-02	17P	Request for examination filed	Effective date: 20140305
2014-07-02	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2014-11-26	DAX	Request for extension of the european patent (deleted)
2015-05-06	RA4	Supplementary search report drawn up and despatched (corrected)	Effective date: 20150408
2015-05-06	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 35/00 20060101ALI20150331BHEP Ipc: A61K 45/06 20060101ALI20150331BHEP Ipc: A61K 31/167 20060101AFI20150331BHEP Ipc: A61K 31/137 20060101ALI20150331BHEP Ipc: A61K 31/4453 20060101ALI20150331BHEP
2018-03-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2018-06-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2018-08-01	18D	Application deemed to be withdrawn	Effective date: 20180301